Jill Johnsen is an Oncology physician affiliated with University of Washington. OpenAlex indexes 169 publications with 8,544 citations (h-index 40); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Eastlake Ave E
Seattle, WA 981094405
Telephone
206-543-3360Registry record last updated 20 Mar 2013.
Clinical trials
- Hemophilia A Research Program
Sponsor: University of Washington
- Von Willebrand Factor in Pregnancy (VIP) Study
Sponsor: University of Washington
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Octapharma USA, Inc.Program year202529 payments$726,277openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20251 payment
- Octapharma USA, Inc.Program year202418 payments$33,119openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Antifibrinolytic Agent100%Tranexamic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Combining large-scale experiments and modeling to dissect the effect of FIXvariants on secretion, carboxylation, activation and disease
University of Washington
FY2026$1,601,223R01HL185768 - A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity
University of Washington
FY2025$2,849,004UH3HL165064 - A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity
University of Washington
FY2024$2,465,319UG3HL165064
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”